Cardiovascular events during carfilzomib therapy for relapsed myeloma: practical management aspects from two case studies

Management of Carfilzomib-Associated Cardiac Adverse Events

(2016) Joseph Mikhael   Clinical Lymphoma Myeloma & Leukemia

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

(2016) Meletios A Dimopoulos et al.   LANCET ONCOLOGY

Cancer Chemotherapy and Cardiac Arrhythmias: A Review

(2015) Juan Tamargo et al.   DRUG SAFETY

Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma

(2015) A. Keith Stewart et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bortezomib-induced acute congestive heart failure: a case report and review of literature

(2014) Ashish Subedi et al.   ANNALS OF HEMATOLOGY

Incidence and Risk of Cardiotoxicity Associated with Bortezomib in the Treatment of Cancer: A Systematic Review and Meta-Analysis

(2014) Yi Xiao et al.   PLoS One

Bortezomib and heart failure: case-report and review of the French Pharmacovigilance database

(2013) Benjamin Honton et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies

(2013) D. Siegel et al.   HAEMATOLOGICA

Severe Heart Failure after Bortezomib Treatment in a Patient with Multiple Myeloma: A Case Report and Review of the Literature

(2012) Margarita Bockorny et al.   ACTA HAEMATOLOGICA

Cancer drugs and the heart: importance and management

(2012) T. M. Suter et al.   EUROPEAN HEART JOURNAL

Bortezomib-Induced Congestive Cardiac Failure in a Patient with Multiple Myeloma

(2011) Ajay Gupta et al.   Cardiovascular Toxicology

Ischemic heart disease associated with bortezomib treatment combined with dexamethasone in a patient with multiple myeloma

(2010) Hiroyuki Takamatsu et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Myocardial scarring following chemotherapy for multiple myeloma detected using late gadolinium hyperenhancement cardiovascular magnetic resonance

(2010) Paul WX Foley et al.   Journal of Cardiovascular Medicine

Epidemiology and risk profile of heart failure

(2010) Anh L. Bui et al.   Nature Reviews Cardiology

Complete Atrioventricular Block Secondary to Bortezomib Use in Multiple Myeloma

(2010) Won-Seop Lee et al.   YONSEI MEDICAL JOURNAL

Complete heart block secondary to bortezomib use in multiple myeloma

(2010) Constantin A Dasanu   JOURNAL OF ONCOLOGY PHARMACY PRACTICE